161 related articles for article (PubMed ID: 18070346)
1. Tetrahydroisoquinoline derivatives: a new perspective on monoaminergic dysfunction in children with ADHD?
Roessner V; Walitza S; Riederer F; Hünnerkopf R; Rothenberger A; Gerlach M; Moser A
Behav Brain Funct; 2007 Dec; 3():64. PubMed ID: 18070346
[TBL] [Abstract][Full Text] [Related]
2. Altered urinary tetrahydroisoquinoline derivatives in patients with Tourette syndrome: reflection of dopaminergic hyperactivity?
Capetian P; Roessner V; Korte C; Walitza S; Riederer F; Taurines R; Gerlach M; Moser A
J Neural Transm (Vienna); 2021 Jan; 128(1):115-120. PubMed ID: 33355691
[TBL] [Abstract][Full Text] [Related]
3. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
Storch A; Ott S; Hwang YI; Ortmann R; Hein A; Frenzel S; Matsubara K; Ohta S; Wolf HU; Schwarz J
Biochem Pharmacol; 2002 Mar; 63(5):909-20. PubMed ID: 11911843
[TBL] [Abstract][Full Text] [Related]
4. Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson's disease.
Scholz J; Klingemann I; Moser A
J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):634-6. PubMed ID: 15026514
[TBL] [Abstract][Full Text] [Related]
5. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
Naoi M; Maruyama W; Nagy GM
Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
[TBL] [Abstract][Full Text] [Related]
6. Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and Parkinson's disease brain.
DeCuypere M; Lu Y; Miller DD; LeDoux MS
J Neurochem; 2008 Dec; 107(5):1398-413. PubMed ID: 19013830
[TBL] [Abstract][Full Text] [Related]
7. Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.
Antkiewicz-Michaluk L; Michaluk J; Romańska I; Papla I; Vetulani J
J Neural Transm (Vienna); 2000; 107(8-9):1009-19. PubMed ID: 11041279
[TBL] [Abstract][Full Text] [Related]
8. Localization of N-methyl-norsalsolinol within rodent and human brain.
DeCuypere M; Kalabokis VN; Hao R; Schroeder D; Miller DD; LeDoux MS
J Neurosci Res; 2008 Aug; 86(11):2543-52. PubMed ID: 18438936
[TBL] [Abstract][Full Text] [Related]
9. Salsolinol and norsalsolinol in human urine samples.
Musshoff F; Daldrup T; Bonte W; Leitner A; Lesch OM
Pharmacol Biochem Behav; 1997 Oct; 58(2):545-50. PubMed ID: 9300617
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives.
Minami M; Maruyama W; Dostert P; Nagatsu T; Naoi M
J Neural Transm Gen Sect; 1993; 92(2-3):125-35. PubMed ID: 8369106
[TBL] [Abstract][Full Text] [Related]
11. Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: in vivo and in vitro studies.
Maruyama W; Dostert P; Naoi M
J Neurochem; 1995 Jun; 64(6):2635-43. PubMed ID: 7760044
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-norsalsolinol, a putative dopaminergic neurotoxin, passes through the blood-brain barrier in vivo.
Thümen A; Behnecke A; Qadri F; Bäuml E; Thümen A; Behnecke CA; Qadri F; Bäuml E; Moser A
Neuroreport; 2002 Jan; 13(1):25-8. PubMed ID: 11924888
[TBL] [Abstract][Full Text] [Related]
13. A systematic regional study of dopamine and dopamine-derived salsolinol and norsalsolinol levels in human brain areas.
Musshoff F; Schmidt P; Dettmeyer R; Priemer F; Wittig H; Madea B
Forensic Sci Int; 1999 Oct; 105(1):1-11. PubMed ID: 10605071
[TBL] [Abstract][Full Text] [Related]
14. Not Just from Ethanol. Tetrahydroisoquinolinic (TIQ) Derivatives: from Neurotoxicity to Neuroprotection.
Peana AT; Bassareo V; Acquas E
Neurotox Res; 2019 Nov; 36(4):653-668. PubMed ID: 31049880
[TBL] [Abstract][Full Text] [Related]
15. Endogenous tetrahydroisoquinolines associated with Parkinson's disease mimic the feedback inhibition of tyrosine hydroxylase by catecholamines.
Scholz J; Toska K; Luborzewski A; Maass A; Schünemann V; Haavik J; Moser A
FEBS J; 2008 May; 275(9):2109-21. PubMed ID: 18355318
[TBL] [Abstract][Full Text] [Related]
16. Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.
Yoshida M; Ogawa M; Suzuki K; Nagatsu T
Adv Neurol; 1993; 60():207-11. PubMed ID: 8093578
[TBL] [Abstract][Full Text] [Related]
17. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.
Maruyama W; Nakahara D; Ota M; Takahashi T; Takahashi A; Nagatsu T; Naoi M
J Neurochem; 1992 Aug; 59(2):395-400. PubMed ID: 1629715
[TBL] [Abstract][Full Text] [Related]
18. Dopamine-derived tetrahydroisoquinolines and Parkinson's disease.
Dostert P; Strolin Benedetti M; Della Vedova F; Allievi C; La Croix R; Dordain G; Vernay D; Durif F
Adv Neurol; 1993; 60():218-23. PubMed ID: 8420138
[TBL] [Abstract][Full Text] [Related]
19. Determination of dopamine and dopamine-derived (R)-/(S)-salsolinol and norsalsolinol in various human brain areas using solid-phase extraction and gas chromatography/mass spectrometry.
Musshoff F; Schmidt P; Dettmeyer R; Priemer F; Jachau K; Madea B
Forensic Sci Int; 2000 Sep; 113(1-3):359-66. PubMed ID: 10978649
[TBL] [Abstract][Full Text] [Related]
20. Catecholamine-derived tetrahydroisoquinolines: O-methylation patterns and regional brain distribution following intraventricular administration in rats.
Collins MA; Origitano TC
J Neurochem; 1983 Dec; 41(6):1569-75. PubMed ID: 6644300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
